Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 214
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07837986 SAFRAN — Investigation of Type I Interferon Excess in Patients With Sys… |
biological samples | Myopathies | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Hospices Civils de Lyon | France · Centre Hospitalier Lyon-Sud, Oullins, France… | 2026-12-01 → 2033-01-01 | Ouvrir |
| NCT07829614 F182112 Phase Ib Clinical Study for the Treatment of Patients With Syst… |
F182112 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Shandong New Time Pharmaceutical … | China · Renji Hospital, Shanghai Jiao Tong University… | 2025-10-30 → 2027-12-31 | Ouvrir |
| NCT07630714 A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety o… |
Anifrolumab + APFS | Lupus | Phase 2 | RECRUITING | En attente / non publié | AstraZeneca | Australia, Belgium, Chile, Israel, Japan, Netherlands… | 2026-08-31 → 2031-09-05 | Ouvrir |
| NCT07301164 Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmu… |
BCT301 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Peking University Third Hospital | China · Peking University Third Hospital, Beijing, Ch… | 2025-12-11 → 2028-12-31 | Ouvrir |
| NCT06839976 CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for… |
CART19 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Children's Hospital of Philadelph… | United States · Children's Hospital of Philadelphia, … | 2025-05-06 → 2030-02-28 | Ouvrir |
| NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Canc… |
Biospecimen Collection | Lupus | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States, Canada · Dana-Farber Cancer Institute,… | 2019-07-16 → 2028-03-30 | Ouvrir |
| NCT07751848 LOTUS — A Study of Outcomes in Chinese Patients Treated With Anifroluma… |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | China · Research Site, Beijing, China | Research Site… | 2026-08-31 → 2028-08-30 | Ouvrir |
| NCT07840287 A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestati… |
Enpatoran | Lupus | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | EMD Serono Research & Development… | United States, Germany · Research Site, Billerica, Un… | 2026-10-15 → 2031-09-01 | Ouvrir |
| NCT05201469 VIBRANT: VIB4920 for Active Lupus Nephritis |
VIB4920 | Lupus | Phase 2 | RECRUITING | En attente / non publié | National Institute of Allergy and… | United States · Columbia University Medical Center: D… | 2022-12-15 → 2028-12 | Ouvrir |
| NCT07823478 HEALTH Home Urinalysis Testing |
Home Urine Testing | Lupus | Non applicable | RECRUITING | En attente / non publié | NYU Langone Health | United States · NYU Langone Health, New York, United … | 2026-09-08 → 2028-09-30 | Ouvrir |
| NCT07823556 The Role of Transforming Growth Factor- Beta (TGF- β) Expression in Ren… |
renal biopsy | Lupus | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Ain Shams University | Egypt · Ain Shams University, Cairo, Egypt | 2026-05-31 → 2027-09-30 | Ouvrir |
| NCT06916806 TITAN — A Study to Investigate Safety, Tolerability, Pharmacokinetics, … |
AZD5492 | Lupus | Phase 1 | RECRUITING | En attente / non publié | AstraZeneca | United States, Canada, China, France, Germany, Hong K… | 2025-05-01 → 2027-09-15 | Ouvrir |
| NCT05672576 OPUS-2 — A Research Study to Evaluate the Efficacy and Safety of Ceneri… |
Cenerimod | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States, Chile, Czechia, Georgia, Germany, Indi… | 2023-06-26 → 2027-06-30 | Ouvrir |
| NCT05648500 OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicin… |
Cenerimod | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States, Argentina, Brazil, Bulgaria, Colombia,… | 2022-12-13 → 2027-09-30 | Ouvrir |
| NCT07328581 A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythema… |
ICG318, BCMA-CD19-IL-15/IL-15 sus… | Lupus | Phase 2 | RECRUITING | En attente / non publié | iCell Gene Therapeutics | United States · Fox Chase Cancer Center- Temple BMT, … | 2026-09 → 2028-12 | Ouvrir |
| NCT06987565 TvSSLE — Transcutaneous Vagus Nerve Stimulation in SLE |
Active vagus nerve stimulation | Lupus | Phase 2 | RECRUITING | En attente / non publié | Northwell Health | United States · Feinstein Institutes for Medical Rese… | 2025-07-25 → 2027-09 | Ouvrir |
| NCT07447986 To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic L… |
SG301 SC Injection | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hangzhou Sumgen Biotech Co., Ltd. | China · Changzhou Second People's Hospital, Changzhou… | 2026-03-26 → 2027-12-31 | Ouvrir |
| NCT06673043 SLE-ARTEMIS — Anifrolumab Real-world Treatment Outcomes in Systemic Lup… |
Anifrolumab | Lupus | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | Poland · Research Site, Bydgoszcz, Poland | Research … | 2025-02-28 → 2028-06-30 | Ouvrir |
| NCT05440422 The Role of Anifrolumab in Improving Markers of Vascular Risk in Patien… |
Anifrolumab | Lupus | Phase 2 | RECRUITING | En attente / non publié | AstraZeneca | United States · National Institutes of Health Clinica… | 2023-12-07 → 2027-08-02 | Ouvrir |
| NCT04902807 ATRACTion — Conception of a Diagnosis, Prognosis and Therapeutic Decisi… |
Collection of samples | Lupus | À vérifier | COMPLETED | En attente / non publié | Institut National de la Santé Et … | France · Hopital Necker Enfants Malades, Paris, France | 2021-09-07 → 2025-10-21 | Ouvrir |
| NCT07748156 SNC116 Therapy for Refractory Systemic Lupus Erythematosus |
SNC116 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | The Affiliated Nanjing Drum Tower… | China · The Affiliated Nanjing Drum Tower Hospital of… | 2026-10 → 2030-01 | Ouvrir |
| NCT07729826 C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refrac… |
C-CAR168 | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | The Affiliated Hospital of Qingda… | Non communiqué | 2026-09-30 → 2029-09-01 | Ouvrir |
| NCT07085104 RESOLUTION — A Study to Investigate the Safety and Preliminary Efficacy… |
ALLO-329 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Allogene Therapeutics | United States, Canada · Astera Cancer Care, East Brun… | 2025-11-13 → 2032-10 | Ouvrir |
| NCT00055055 Study of Families With Twins or Siblings Discordant for Rheumatic Disor… |
Study of Families With Twins or S… | Lupus | À vérifier | COMPLETED | En attente / non publié | National Institute of Environment… | United States · National Institutes of Health Clinica… | 2003-04-21 | Ouvrir |
| NCT05538208 The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study |
Mycophenolate Mofetil | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States · Akron Children's Hospital, Akron, Uni… | 2024-06-07 → 2027-01 | Ouvrir |